+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Injectable Drugs Market by Molecule Type (Large Molecule, Small Molecule), Drug Class (Blood Factors, Cytokines, Immunoglobulin), Injection Routes, Application - Forecast 2024-2030- Product Image
Global Injectable Drugs Market by Molecule Type (Large Molecule, Small Molecule), Drug Class (Blood Factors, Cytokines, Immunoglobulin), Injection Routes, Application - Forecast 2024-2030- Product Image
Sale

Global Injectable Drugs Market by Molecule Type (Large Molecule, Small Molecule), Drug Class (Blood Factors, Cytokines, Immunoglobulin), Injection Routes, Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5716156
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Injectable Drugs Market size was estimated at USD 563.30 billion in 2023, USD 617.04 billion in 2024, and is expected to grow at a CAGR of 9.86% to reach USD 1,088.55 billion by 2030.

The injectable drugs market comprises sales and distribution of medications and therapies that are administered through intravenous (IV), intramuscular (IM), or subcutaneous (SC) injection routes. The market caters to various drugs, including antibiotics, insulin, vaccines, and oncology treatments, that are integral in treating multiple diseases and medical conditions. Injectable drugs have diverse applications ranging from emergency care to routine administration of chronic disease medications. They are used in hospitals, clinics, and, increasingly, self-care settings due to advancements in auto-injection devices.

Several factors, such as the rising burden of chronic diseases, the growing use of prefilled and self-injectable drugs, and the ongoing practice of steady drug delivery vehicles for cancer treatment, drive the development of the injectable drugs market. However, the market faces limitations and challenges, including high research and development costs, regulatory compliance costs, and complex manufacturing processes under stringent conditions. On the other hand, new opportunities are emerging due to rapid developments and approvals in injectable drugs and strategic alliances among manufacturers for injectable drugs. Moreover, improving drug delivery methods' safety, convenience, and efficacy can lead to increased patient compliance and better outcomes.

Regional Insights

In the Americas, particularly in the United States and Canada, there is a high demand for injectable drugs due to the prevalence of diseases such as diabetes and cancer. Advanced healthcare infrastructure and high per capita healthcare expenditure drive the innovation and adoption of new injection technologies. Drug efficacy, safety profiles, and ease of use influence customer purchasing behavior in these markets. South America's market for injectable drugs is growing steadily due to improving healthcare facilities, increasing economic stability, and governmental support for healthcare reforms in countries such as Brazil, Argentina, and Chile.

Europe represents a developing injectable drug market with well-established healthcare systems and favorable reimbursement policies. Eastern European countries are experiencing faster growth rates due to increased accessibility to advanced therapeutics. The Middle East, with countries such as Saudi Arabia and the UAE, shows a promising injectable drugs market due to rising healthcare infrastructure and increasing private sector investments. Africa, on the other hand, is progressively adopting injectable drug therapies but faces challenges related to affordability and access to medicine. The APAC region is emerging as the fastest-growing market for injectable drugs, driven by economic growth, expanding healthcare sectors, and increasing investments in biopharmaceutical research. Countries such as China, India, and Japan are at the forefront, with a high demand for both generic and innovative injectable drugs. In China, local manufacturing and foreign investment are extensive, catering to a vast domestic market. Japan is known for its technological advancements and invests heavily in pharmaceutical R&D, including next-generation injectable treatments. With a burgeoning pharmaceutical industry, India offers a large market for injectable drugs. Low-cost manufacturing and a growing middle class impact purchasing behaviors favorably toward more affordable injectable options.

Market Trends by Segment

  • Drug Class: Increasing preference for cytokines injectable protein for cell signaling
  • Application: Growing application of injectable drugs for treating autoimmune diseases

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Sun Pharma and Taro announce merger agreement

Sun Pharmaceutical Industries Ltd. and Taro Pharmaceutical Industries Ltd. agreed upon a definitive merger, wherein Sun Pharma is expected to purchase the remaining outstanding shares of Taro for USD 43 per share in cash, totaling USD 347.73 million. This acquisition is going to result in Taro becoming a privately held subsidiary of Sun Pharma.

Glenmark launched Biosimilar of Popular Anti-Diabetic Drug, Liraglutide, in India

Glenmark Pharmaceuticals Ltd. announced the Indian market introduction of Lirafit, a cost-effective biosimilar to the widely used anti-diabetic drug Liraglutide. With this launch, Glenmark has ventured into the injectable anti-diabetic market, taking another significant stride in the diabetes therapy space.

Bristol Myers' injectable form of Opdivo meets main goal in kidney cancer trial

Bristol Myers Squibb announced a significant advancement in administering itsoncology medication, Opdivo, having successfully trialed a new injectable form that streamlines the treatment process for kidney cancer patients. This injectable version utilizes Halozyme Therapeutics' innovative technology to facilitate a subcutaneous delivery, potentially revolutionizing patient and physician treatment experiences.

Key Company Profiles

The report delves into recent significant developments in the Injectable Drugs Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Amgen Inc., AstraZeneca PLC, Baxter International Inc., Biogen Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Chiesi Farmaceutici S.p.A., Cipla Limited, Daiichi Sankyo Co., Ltd., Dr. Reddy’s Laboratories Ltd., Eagle Pharmaceuticals, Inc., Eli Lilly and Company, EVER Neuro Pharma GmbH, F. Hoffmann-La Roche Ltd., Ferring B.V., Fresenius Kabi AG, Gilead Sciences, Inc., GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A., SCHOTT PHARMA AG & CO. KGAA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.

This research report offers invaluable insights into various crucial aspects of the Injectable Drugs Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Burden of Chronic Diseases
5.1.1.2. Growing Use of Prefilled and Self-Injectable Drugs
5.1.1.3. Ongoing Practice of Controlled Drug Delivery Vehicles for Cancer Treatment
5.1.2. Restraints
5.1.2.1. Rise in Incidences of Product Recall
5.1.3. Opportunities
5.1.3.1. Rapid Developments and Approvals in Injectable Drugs
5.1.3.2. Strategic Alliances Among Manufacturers for Injectable Drugs
5.1.4. Challenges
5.1.4.1. Complex Manufacturing Process and Shortages of Injectable Drugs
5.2. Market Segmentation Analysis
5.2.1. Drug Class: Increasing preference for cytokines injectable protein for cell signaling
5.2.2. Application: Growing application of injectable drugs for treating autoimmune diseases
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Injectable Drugs Market, by Molecule Type
6.1. Introduction
6.2. Large Molecule
6.3. Small Molecule
7. Injectable Drugs Market, by Drug Class
7.1. Introduction
7.2. Blood Factors
7.3. Cytokines
7.4. Immunoglobulin
7.5. Insulin
7.6. Monoclonal Antibodies
7.7. Peptide Hormone
8. Injectable Drugs Market, by Injection Routes
8.1. Introduction
8.2. Intramuscular
8.3. Intraocular
8.4. Intrathecal
8.5. Intravenous
8.6. Subcutaneous
9. Injectable Drugs Market, by Application
9.1. Introduction
9.2. Autoimmune Diseases
9.3. Cardiovascular Diseases
9.4. Infectious Diseases
9.5. Neurology
9.6. Oncology
9.7. Pain
10. Americas Injectable Drugs Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Injectable Drugs Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Injectable Drugs Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Sun Pharma and Taro announce merger agreement
13.3.2. Glenmark launched Biosimilar of Popular Anti-Diabetic Drug, Liraglutide, in India
13.3.3. Bristol Myers' injectable form of Opdivo meets main goal in kidney cancer trial
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. INJECTABLE DRUGS MARKET RESEARCH PROCESS
FIGURE 2. INJECTABLE DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL INJECTABLE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. INJECTABLE DRUGS MARKET DYNAMICS
FIGURE 7. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
FIGURE 10. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2023 VS 2030 (%)
FIGURE 12. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES INJECTABLE DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES INJECTABLE DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. INJECTABLE DRUGS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. INJECTABLE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. INJECTABLE DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL INJECTABLE DRUGS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL INJECTABLE DRUGS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY LARGE MOLECULE, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY LARGE MOLECULE, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY BLOOD FACTORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY BLOOD FACTORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY CYTOKINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY CYTOKINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY INSULIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY INSULIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY PEPTIDE HORMONE, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY PEPTIDE HORMONE, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY INTRAOCULAR, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY INTRAOCULAR, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY INTRATHECAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY INTRATHECAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY PAIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL INJECTABLE DRUGS MARKET SIZE, BY PAIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 69. ARGENTINA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. ARGENTINA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. BRAZIL INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 72. BRAZIL INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 75. BRAZIL INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 76. BRAZIL INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 77. BRAZIL INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 78. BRAZIL INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 79. CANADA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 80. CANADA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 81. CANADA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 82. CANADA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 83. CANADA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 84. CANADA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 85. CANADA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 86. CANADA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 87. MEXICO INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 88. MEXICO INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 89. MEXICO INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 90. MEXICO INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 91. MEXICO INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 92. MEXICO INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 93. MEXICO INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 94. MEXICO INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 95. UNITED STATES INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 96. UNITED STATES INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 97. UNITED STATES INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 98. UNITED STATES INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 99. UNITED STATES INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 100. UNITED STATES INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 101. UNITED STATES INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. UNITED STATES INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. UNITED STATES INJECTABLE DRUGS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 104. UNITED STATES INJECTABLE DRUGS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 106. ASIA-PACIFIC INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 108. ASIA-PACIFIC INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 110. ASIA-PACIFIC INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. ASIA-PACIFIC INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 114. ASIA-PACIFIC INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 115. AUSTRALIA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 116. AUSTRALIA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 117. AUSTRALIA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 118. AUSTRALIA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 119. AUSTRALIA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 120. AUSTRALIA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 121. AUSTRALIA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 122. AUSTRALIA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 123. CHINA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 124. CHINA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 125. CHINA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 126. CHINA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 127. CHINA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 128. CHINA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 129. CHINA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 130. CHINA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 131. INDIA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 132. INDIA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 133. INDIA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 134. INDIA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 135. INDIA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 136. INDIA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 137. INDIA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 138. INDIA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 139. INDONESIA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 140. INDONESIA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 141. INDONESIA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 142. INDONESIA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 143. INDONESIA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 144. INDONESIA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 145. INDONESIA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 146. INDONESIA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 147. JAPAN INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 148. JAPAN INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 149. JAPAN INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 150. JAPAN INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 151. JAPAN INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 152. JAPAN INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 153. JAPAN INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 154. JAPAN INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 155. MALAYSIA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 156. MALAYSIA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 157. MALAYSIA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 158. MALAYSIA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 159. MALAYSIA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 160. MALAYSIA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 161. MALAYSIA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 162. MALAYSIA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 163. PHILIPPINES INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 164. PHILIPPINES INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 165. PHILIPPINES INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 166. PHILIPPINES INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 167. PHILIPPINES INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 168. PHILIPPINES INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 169. PHILIPPINES INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 170. PHILIPPINES INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 171. SINGAPORE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 172. SINGAPORE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 173. SINGAPORE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 174. SINGAPORE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 175. SINGAPORE INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 176. SINGAPORE INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 177. SINGAPORE INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 178. SINGAPORE INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 179. SOUTH KOREA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 180. SOUTH KOREA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 181. SOUTH KOREA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 182. SOUTH KOREA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 183. SOUTH KOREA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 184. SOUTH KOREA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 185. SOUTH KOREA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 186. SOUTH KOREA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 187. TAIWAN INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 188. TAIWAN INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 189. TAIWAN INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 190. TAIWAN INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 191. TAIWAN INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 192. TAIWAN INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 193. TAIWAN INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 194. TAIWAN INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 195. THAILAND INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 196. THAILAND INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 197. THAILAND INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 198. THAILAND INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 199. THAILAND INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 200. THAILAND INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 201. THAILAND INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 202. THAILAND INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 203. VIETNAM INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 204. VIETNAM INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 205. VIETNAM INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 206. VIETNAM INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 207. VIETNAM INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 208. VIETNAM INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 209. VIETNAM INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 210. VIETNAM INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 221. DENMARK INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 222. DENMARK INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 223. DENMARK INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 224. DENMARK INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 225. DENMARK INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 226. DENMARK INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 227. DENMARK INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 228. DENMARK INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 229. EGYPT INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 230. EGYPT INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 231. EGYPT INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 232. EGYPT INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 233. EGYPT INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 234. EGYPT INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 235. EGYPT INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. EGYPT INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. FINLAND INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 238. FINLAND INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 239. FINLAND INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 240. FINLAND INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 241. FINLAND INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 242. FINLAND INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 243. FINLAND INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 244. FINLAND INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 245. FRANCE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 246. FRANCE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 247. FRANCE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 248. FRANCE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 249. FRANCE INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 250. FRANCE INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 251. FRANCE INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 252. FRANCE INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 253. GERMANY INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 254. GERMANY INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 255. GERMANY INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 256. GERMANY INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 257. GERMANY INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 258. GERMANY INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 259. GERMANY INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. GERMANY INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. ISRAEL INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 262. ISRAEL INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 263. ISRAEL INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 264. ISRAEL INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 265. ISRAEL INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 266. ISRAEL INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 267. ISRAEL INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 268. ISRAEL INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 269. ITALY INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 270. ITALY INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 271. ITALY INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 272. ITALY INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 273. ITALY INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 274. ITALY INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 275. ITALY INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 276. ITALY INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 277. NETHERLANDS INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 278. NETHERLANDS INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 279. NETHERLANDS INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 280. NETHERLANDS INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 281. NETHERLANDS INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 282. NETHERLANDS INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 283. NETHERLANDS INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 284. NETHERLANDS INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 285. NIGERIA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 286. NIGERIA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 287. NIGERIA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 288. NIGERIA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 289. NIGERIA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 290. NIGERIA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 291. NIGERIA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 292. NIGERIA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 293. NORWAY INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 294. NORWAY INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 295. NORWAY INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 296. NORWAY INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 297. NORWAY INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 298. NORWAY INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 299. NORWAY INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 300. NORWAY INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 301. POLAND INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 302. POLAND INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 303. POLAND INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 304. POLAND INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 305. POLAND INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 306. POLAND INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 307. POLAND INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 308. POLAND INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 309. QATAR INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 310. QATAR INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 311. QATAR INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 312. QATAR INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 313. QATAR INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 314. QATAR INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 315. QATAR INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 316. QATAR INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 317. RUSSIA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 318. RUSSIA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 319. RUSSIA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 320. RUSSIA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 321. RUSSIA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 322. RUSSIA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 323. RUSSIA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 324. RUSSIA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 325. SAUDI ARABIA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 326. SAUDI ARABIA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 328. SAUDI ARABIA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 329. SAUDI ARABIA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 330. SAUDI ARABIA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 331. SAUDI ARABIA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 332. SAUDI ARABIA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 333. SOUTH AFRICA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 334. SOUTH AFRICA INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 335. SOUTH AFRICA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 336. SOUTH AFRICA INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 337. SOUTH AFRICA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 338. SOUTH AFRICA INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 339. SOUTH AFRICA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 340. SOUTH AFRICA INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 341. SPAIN INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 342. SPAIN INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 343. SPAIN INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 344. SPAIN INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 345. SPAIN INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 346. SPAIN INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 347. SPAIN INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 348. SPAIN INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 349. SWEDEN INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
TABLE 350. SWEDEN INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
TABLE 351. SWEDEN INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 352. SWEDEN INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 353. SWEDEN INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2018-2023 (USD MILLION)
TABLE 354. SWEDEN INJECTABLE DRUGS MARKET SIZE, BY INJECTION ROUTES, 2024-2030 (USD MILLION)
TABLE 355. SWEDEN INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 356. SWEDEN INJECTABLE DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 357. SWITZERLAND INJECTABLE D

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Baxter International Inc.
  • Biogen Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Chiesi Farmaceutici S.p.A.
  • Cipla Limited
  • Daiichi Sankyo Co., Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Eagle Pharmaceuticals, Inc.
  • Eli Lilly and Company
  • EVER Neuro Pharma GmbH
  • F. Hoffmann-La Roche Ltd.
  • Ferring B.V.
  • Fresenius Kabi AG
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Sanofi S.A.
  • SCHOTT PHARMA AG & CO. KGAA
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages186
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 617.04 Billion
Forecasted Market Value ( USD ) by 2030 $ 1088.55 Billion
Compound Annual Growth Rate9.8%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Global Generic Injectables Market by Product (Large Molecule Injectables, Small Molecule Injectables), Type (Cytokines, Insulin, Monoclonal Antibodies), Application, Distribution Channel - Forecast 2024-2030 - Product Image

Global Generic Injectables Market by Product (Large Molecule Injectables, Small Molecule Injectables), Type (Cytokines, Insulin, Monoclonal Antibodies), Application, Distribution Channel - Forecast 2024-2030

  • Report
  • 188 Pages
  • Global
From
Global Sterile Injectable Drugs Market by Molecule Type (Large Molecule, Small Molecule), Drug (Blood Factors, Cytokines, Immunoglobulins), Indication, Distribution - Forecast 2024-2030 - Product Image

Global Sterile Injectable Drugs Market by Molecule Type (Large Molecule, Small Molecule), Drug (Blood Factors, Cytokines, Immunoglobulins), Indication, Distribution - Forecast 2024-2030

  • Report
  • 197 Pages
  • Global
From
Injectable Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Injectable Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 115 Pages
  • Global
From
Global Sterile Injectable Contract Manufacturing Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - Product Image

Global Sterile Injectable Contract Manufacturing Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030

  • Report
  • 270 Pages
  • Global
Sterile Injectable Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Sterile Injectable Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 249 Pages
  • Global

About the Injectable Pharmaceuticals Market

The Injectable Pharmaceuticals market is a subset of the Pharmaceuticals industry, focusing on the production and distribution of drugs that are administered via injection. These drugs are typically used to treat serious medical conditions, such as cancer, heart disease, and autoimmune disorders. Injectable Pharmaceuticals are typically more expensive than other forms of medication, due to the complexity of their production and the need for specialized equipment. Injectable Pharmaceuticals are typically produced by large pharmaceutical companies, which have the resources and expertise to develop and manufacture these drugs. These companies often collaborate with smaller companies to develop and market their products. Examples of companies in the Injectable Pharmaceuticals market include Pfizer, Merck, Novartis, and Sanofi. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.